Advertisement
Screener

TSCAN THERAPEUTICS, INC. (TCRX) Authorized Dilution

TSCAN THERAPEUTICS, INC. Authorized Dilution

Share-issuance capacity and approved equity plans, with the disclosed share class, period, approval and expiry. Gross charter headroom is authorized minus issued shares, not a forecast. Equity plan reserves may use weighted counting rules, overlap charter capacity, and must not be added to it. Outstanding awards, future grants, and proposed approvals are distinct. * denotes calculated capacity.

As ofAuthorization / planShare classAuthorized / approved limit (shares)Issued shares / outstanding awards (shares)Remaining capacity (shares / reserve units)Approval statusApproval dateExpiry / conditionsBasis / limitationsSource

Similar stocks

Stock NameCountryMarket CapPE Ratio
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
IN8BIO, INC. (INAB)United States$0.012B-0.76
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B